1. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. Issue 6 (1st December 1999) Authors: Patel, R; Tyring, S; Strand, A; Price, M J; Grant, D M Journal: Sexually transmitted infections Issue: Volume 75:Issue 6(1999) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O3-S5.01 Impact of AIC316, a novel antiviral helicase-primase inhibitor, on genital HSV shedding: randomised, double-blind, placebo-controlled trial. (10th July 2011) Authors: Wald, A; Stoelben, S; Tyring, S; Warren, T; Johnston, C; Huang, M L; Timmler, B; Ruebsamen-Schaeff, H; Corey, L; Birkmann, A Journal: Sexually transmitted infections Issue: Volume 87(2011)Supplement 1 Page Start: A78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗